Advertise
NEWSLETTER
Allergan Aesthetics highlig...
Insilico, Tenacia expand AI...
New AI research reshapes ne...
Scalable biotech manufactur...
Cellbricks Therapeutics sec...
Allergan Aesthetics highlig...
Insilico, Tenacia expand AI...
New AI research reshapes ne...
Scalable biotech manufactur...
Cellbricks Therapeutics sec...
Agetech
Clearday and Viveon Health SPAC announce merger agreement to accelerate innovative longevity tech

Clearday and Viveon Health SPAC announce merger agreement to accelerate innovative longevity tech

Celebrating International Women’s Day, we reflect on just some of the pioneering women we have written about over the last few months.

International Women’s Day: the wonderful women of longevity

Portfolia’s latest AgeTech investment leaves Toi Labs flushed with success

Portfolia’s latest AgeTech investment leaves Toi Labs flushed with success

Female investor group backs creator of AI-powered smart toilet seat that continually monitors users’ health. Investment

Rosita longevity

Rosita Longevity over 60s health app launches in US

Aging in place report, download for free.

Aging in place: technologies to live long and independently

Honor & Homestead

Honor acquires Home Instead – big news for aging in place

Dan Vahdat

Huma’s $130m raise will scale its digital health platform

London

New investor offers funding to healthy aging innovators

AgeTech fund: focus on over-50s not millennials

Hundreds of companies are working to develop treatments to slow down aging and increase healthy longevity. Read about them here.

2021 hits the longevity ground running

Project 21 & Aubrey de Grey

Rejuveron appoints anti-aging pioneer to Scientific Advisory Board

Longevity companies to watch in 2021

Juvenesence's Greg Bailey on transformative scientific opportunities, immuno-resilience and modifying aging.

Juvenescence (1): from strength to strength in R&D and investment firepower

A year in Longevity: different perspectives

A year in Longevity: science perspectives

Sigilon IPO raises $145m to address chronic diseases

Silicon Valley is waking up to Longevity and senolytics

UK start-up Cera, a technology-enabled home care provider, is one of Europe’s fastest-growing businesses with $120m in revenue.

Healthtech start-up reaches $120m revenue in under four years

Alon Braun, Neurotech founder

Neurotech2020 – a clear head for neurotech, research and investment

Longevity investing: A UBS Investor Watch survey shows that investors would sacrifice wealth for an extra ten years of healthy life.

Would you invest $1000 per week to live longer?

ChromaDex CEO Rob Fried

Exclusive: ChromaDex’s CEO on Longevity commercialisation

Tina Woods: Prevention is vital for Longevity

Wearable firm switches focus to enterprise

Healthspan wearables and subscription services are hot!

Why government must unlock biotech’s potential to maximise Longevity

Jinfiniti, NetraMark and Scarlette Lillie will explore the role psilocybin can play for age-related diseases.

Jinfiniti’s Startup Showcase success drives collaboration

Proposed budget cut: reduced Longevity for EU citizens?

Longevity 1.0 – new book seeks to define Longevity

Balancing the Longevity books: “biological aging is malleable”

Primetime Partners get ready for Longevity primetime

Biofourmis raises $100M to scale digital therapeutics

Lorraine Morley from Allia

AgeTech investment: “there is everything to play for”

Credit: wayhomestudio/Freepik

Targeting multiple Longevity biomarkers in a single panel

Juvenescence (2): “It’s all about prevention, and that’s incredibly disruptive”

Longevity opportunities in the post-Covid world

Tonus seeks early-stage funding for exoskeleton tech

VC enters Longevity market with K4Connect deal

Sun Genomics raises $8.5m to drive market share

Real-time tracking of 400+ Longevity biomarkers

Making the Longevity grade: expanded list of 1000 leading names

Alex Zhavoronkov is pushing for us to examine how and when to classifying aging and how it should be implemented to overcome "inherent challenges"

Classifying aging as a disease – it’s all about the ‘how’

The latest longevity science, investment, innovation and insight, delivered every morning.

This field is hidden when viewing the form